Race to Publish May Have Been GlaxoSmithKline (GSK)'s Downfall
8/8/2013 7:22:10 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Liu Xuebin recalls working 12-hour shifts and most weekends for months, under pressure to announce research results that would distinguish his GlaxoSmithKline Plc (GSK) lab in China as a force in multiple sclerosis research. It paid off -- for a while. Nature Medicine published findings about a potential new MS treatment approach in January 2010 and months later Liu was promoted to associate director of Glaxo’s global center for neuro-inflammation research in Shanghai. Two months ago, his career unraveled.
Help employers find you! Check out all the jobs and post your resume.
comments powered by